Decoy Therapeutics is trading at $3.06, up +5.47%, with no clear catalyst identified.
- No company-specific announcement, filing, earnings release, or major event dated August 31, 2026, was identified in available coverage.
- Recent indexed company news concerns an August 3 intellectual-property update, not a new August 31 catalyst.
- The gain is occurring despite softer broad-market conditions, leaving the cause unclear. Recheck later for delayed filings or developments.